Fulcrum therapeutics® to participate at upcoming november investor conferences

Cambridge, mass., nov. 01, 2022 (globe newswire) -- fulcrum therapeutics, inc.  (nasdaq: fulc), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that management will participate in the following upcoming investor conferences:
FULC Ratings Summary
FULC Quant Ranking